Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SLE: idiopathic or drug-induced?

J J Condemi

    Geriatrics
    |March 1, 1980
    PubMed
    Summary

    Procainamide frequently causes drug-induced lupus, resembling SLE but with key differences. While stopping the drug often resolves symptoms, acetylation status may influence disease development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.

    Clinical therapeutics·2001
    Same author

    Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists.

    The Journal of allergy and clinical immunology·1999
    Same author

    The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1999
    Same author

    Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.

    The Journal of allergy and clinical immunology·1997
    Same author

    Urticaria. Evaluation and treatment.

    Polskie Archiwum Medycyny Wewnetrznej·1997
    Same author

    Update in allergy and immunology.

    Annals of internal medicine·1996

    Area of Science:

    • Rheumatology
    • Clinical Pharmacology
    • Immunology

    Background:

    • Procainamide is a common cause of drug-induced lupus erythematosus (DILE).
    • DILE induced by procainamide shares similarities with idiopathic systemic lupus erythematosus (SLE) but has distinct characteristics.
    • These differences include variations in race and sex distribution, less frequent kidney and central nervous system involvement, and absence of anti-native DNA antibodies.

    Purpose of the Study:

    • To investigate the relationship between procainamide use and the development of drug-induced lupus syndrome.
    • To identify factors that may predispose individuals to procainamide-induced lupus.
    • To understand the clinical manifestations and remission patterns of procainamide-induced lupus.

    Main Methods:

    • Observational analysis of patients treated with procainamide.
    • Monitoring for the development of antinuclear antibodies (ANA) and lupus syndrome.
    • Assessment of clinical symptoms, disease characteristics, and response to drug discontinuation.

    Main Results:

    • Procainamide therapy can lead to the development of ANA in over 50% of patients and lupus syndrome in approximately 20%.
    • Complete remission is achieved in most patients after discontinuing procainamide, though some require corticosteroid treatment.
    • Neither cumulative nor daily dosage of procainamide appears to be the sole factor in the onset of ANA or symptoms.

    Conclusions:

    • Procainamide is a significant inducer of drug-induced lupus syndrome.
    • Acetylation status is suggested as a potential determining factor in the development of procainamide-induced SLE.
    • While drug withdrawal is often effective, individualized management may be necessary for persistent symptoms.

    Related Experiment Videos